Sanofi To Divest 60% Of Brands In Consumer Healthcare Overhaul
Executive Summary
Sanofi will look to offload around 150 OTC brands as part of a radical overhaul of its Consumer Healthcare operation. The new head of the business Julie Van Ongevalle has unveiled a wide-ranging turnaround plan with the goal of transforming Sanofi into the OTC market leader.
You may also be interested in...
J&J Rides Standalone Consumer Health Track
J&J takes same approach GSK, Pfizer, Merck & Co, Merck and Novartis have with their consumer health businesses, Bausch Health is starting and Sanofi says it will.
Sanofi Catching Up To Market Growth Rates As Q3 Sales Rise Double Digits
Sanofi Consumer Healthcare's second successive quarter of growth means the business is now growing almost as fast as the global OTC market. Business head Julie Van Ongevalle has won praise from the French group's CEO Paul Hudson for driving a "quite extraordinary" transformation.
Euro Q3 Consumer Health Earnings Preview: GSK, Sanofi, Bayer And Reckitt
Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt continue to deal with the fallout of the COVID-19 pandemic while implementing long-term strategies to drive growth. This earnings preview highlights what to look out for as these four firms report their third-quarter results over the coming weeks.